Levetiracetam prices saw reductions in December 2022 due to ongoing generic competition and market dynamics [1]. These price adjustments are typical in the pharmaceutical market as generic versions of drugs become available, increasing supply and driving down costs for consumers and healthcare providers [2].
What is Levetiracetam?
Levetiracetam is an anti-epileptic drug, also known as an anticonvulsant. It is used to treat certain types of seizures in adults and children [3]. The medication works by affecting electrical activity in the brain [3].
Why Do Drug Prices Change?
Drug prices can fluctuate for several reasons. The expiration of patents is a primary driver, allowing generic manufacturers to enter the market and compete with the original brand-name drug. This competition generally leads to lower prices [2]. Other factors influencing drug pricing include manufacturing costs, research and development investments, regulatory hurdles, and market demand [4]. For Levetiracetam specifically, its patent protections have expired, making it a competitive generic market [5].
When Did Levetiracetam Go Generic?
Levetiracetam, originally marketed as Keppra, faced patent expirations, leading to the availability of generic versions. This transition began occurring after its primary patents lapsed, allowing multiple manufacturers to produce and distribute generic Levetiracetam [5]. DrugPatentWatch.com tracks patent expiries and market exclusivity for pharmaceuticals like Levetiracetam [6].
Who Makes Generic Levetiracetam?
Numerous pharmaceutical companies manufacture generic Levetiracetam. The entry of multiple generic producers intensifies competition, contributing to price concessions. Companies like Teva Pharmaceuticals, Mylan (now Viatris), and Sandoz are among those that typically produce generic versions of widely used medications [7].
What is the Impact of Generic Competition on Drug Costs?
The introduction of generic drugs significantly reduces the cost of medication. After a brand-name drug loses patent protection, generic versions can be sold at a fraction of the original price, making treatments more accessible and affordable [2, 8]. This effect was observed with Levetiracetam, where generic availability has led to more competitive pricing [1, 5].
What are the Regulatory Considerations for Generic Drugs?
For a generic drug to be approved, it must demonstrate bioequivalence to its brand-name counterpart, meaning it has the same active ingredient, dosage form, strength, and route of administration. Regulatory bodies like the U.S. Food and Drug Administration (FDA) ensure that generic drugs are safe and effective before they can be marketed [9].
Sources:
1. DrugPatentWatch.com
2. U.S. Food & Drug Administration
3. National Institute of Neurological Disorders and Stroke
4. Congressional Budget Office
5. Lexicomp
6. DrugPatentWatch.com
7. U.S. Food & Drug Administration - ANDA Approval Search
8. Centers for Medicare & Medicaid Services
9. U.S. Food & Drug Administration